7
Participants
Start Date
March 17, 2017
Primary Completion Date
October 18, 2018
Study Completion Date
October 18, 2018
CAR-GPC3 T cells
"Self-controlled dose escalation will be applied to the first 3 - 6 subjects enrolled.~Classical 3+3 dose escalation will be applied to subsequent subjects based on the self-controlled dose escalation study."
Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai
Collaborators (1)
CARsgen Therapeutics Co., Ltd.
INDUSTRY
RenJi Hospital
OTHER